FIS/HIS International 2022 will be delivered as a two-day face-to-face and one day virtual event, with all content available on demand post-event. The programme will include plenary lectures, >30 scientific sessions, sponsored symposia, a trainee session and more.
All delegates who register to attend the across three days will, for the first time in the history of the event, be able to access the content from all four parallel sessions every day.
The scientific content of the first two days (Thursday 22 and Friday 23 September) will be recorded and, after a weekend break, Monday 26 September will be entirely virtual with parallel sessions broadcast live. Content will be available on demand to all registered attendees after the event.
Professor Jan Kluytmans, UMC Utrecht
Jan Kluytmans did his medical training as well as specialization in Clinical Microbiology at Erasmus Medical University, Rotterdam, The Netherlands. The title of his PhD thesis in 1996, was: Nasal carriage of Staphylococcus aureus: the key to preventing staphylococcal disease.
His scientific career focuses on the epidemiology and control of nosocomial infections, with a special interest in Staphylococcus aureus, surgical site infections and catheter related infections. He discovered the concept of perioperative eradication of nasal carriage which is now incorporated in the WHO guidelines on the prevention of Surgical site infections. More recently his investigations have included the impact of agricultural antibiotic use on the development of resistance in animals, food items and humans.
He has been involved in many national and international guidelines on infection control, especially those dealing with the control of MRSA and the prevention of surgical site infections. Until 2013 he was the chair of the Dutch Working Party on Infection Control. From 2006 – 2017 he was a Professor of Medical Microbiology and Infection Control at the VU university medical center in Amsterdam. From 2013-2019 he was the chair of the Dutch Society of Medical Microbiology. Since the start of the pandemic he is member of the Dutch outbreak management team for COVID-19. At present he is head of the department of medical microbiology of the University Medical Center Utrecht.
He has more than 350 papers in peer-reviewed journals and given more than 500 presentations and lectures.
Professor Dame Sally Davies, Master of Trinity College and UK Special Envoy on Antimicrobial Resistance
Dame Sally Davies was appointed as the UK Government’s Special Envoy on AMR in 2019. She is also the 40th Master of Trinity College, Cambridge University.
Dame Sally was the Chief Medical Officer for England and Senior Medical Advisor to the UK Government from 2011-2019. She is a leading figure in global health, having served as a member of the World Health Organisation (WHO) Executive Board 2014-2016, and as co-convener of the United Nations Inter-Agency Co-ordination Group (IACG) on Antimicrobial Resistance (AMR), reporting in 2019. In November 2020, Dame Sally was announced as a member of the new UN Global Leaders Group on AMR, serving alongside Heads of State, Ministers and prominent figures from around the world to advocate for action on AMR
In the 2020 New Year Honours, Dame Sally became the second woman (and the first outside the Royal family) to be appointed Dame Grand Cross of the Order of the Bath (GCB) for services to public health and research, having received her DBE in 2009.
Professor Nick Beeching
Emeritus Professor and Honorary Consultant in Tropical and Infectious Diseases, Liverpool School of Tropical Medicine and Liverpool University Hospitals Foundation NHS Trust.
Nick Beeching has had a varied career, following early training in Oxford, Liverpool, Adelaide, Birmingham, Riyadh and Auckland and his first consultant post in Khamis Mushayt, Saudi Arabia. Since 1987 he has been a clinician, postgraduate educator and researcher in Liverpool, with leadership roles in several UK and European ID societies, postgraduate education and examination boards. His many medical interests are making it difficult for him to retire.
Professor Alison Holmes, Imperial College London
Alison Holmes is a Professor of Infectious Diseases and the Director of both the NIHR Health Protection Research Unit in Healthcare Associated Infections and AMR and the Centre for Antimicrobial Optimisation (CAMO), at Imperial College London. She leads a large multidisciplinary infectious disease research programme focusing on antimicrobial resistance, epidemiology, public health, precision medicine and the development of emerging, innovative technologies to address infection prevention and management, antibiotic optimisation and AMR nationally and globally. She leads an ESRC international programme with collaborators in India and South Africa, as well as Wellcome Trust-funded projects led by colleagues in the Department of Electrical and Electronic Engineering and collaborators in Vietnam and Thailand.
Professor Holmes is a Fellow of the Academy of Medical Sciences, an NIHR Senior Investigator and an Infectious Disease consultant within Imperial College Healthcare NHS Trust. Until June 2021, she was also the Associate Medical Director, Director of Infection Prevention and Control at the Trust. Throughout her longstanding clinical and research career Professor Holmes has conducted clinically applied research that influences local, national and international practice. She served as an expert member of the Governmental Advisory Committee on AMR and Healthcare Associated Infection for nine years and as a national expert witness for Parliamentary Health and Science and Technology Committees.
Professor Holmes is the current President of the International Society for Infectious Diseases, and serves on a variety of WHO Expert groups related to antimicrobial use, AMR, infection prevention and sepsis. In addition to her role as chair or advisor for numerous international scientific advisory boards, funding panels and editorial boards she is the outgoing Chair of the Fleming Fund’s Technical Advisory Group (Department of Health and Social Care), a former Board Member of the Wellcome Trust’s Surveillance & Epidemiology of Drug-resistant Infections Consortium (SEDRIC) and has recently joined the Scientific Advisory Board of the Helmholtz Association of German Research Centres.
In response to the COVID-19 pandemic Professor Holmes has contributed to national COVID-19 responses through the UK Scientific Advisory Group for Emergencies (SAGE) Hospital Onset COVID-19 working group and her research group’s work in this field. She has also been active in the international responses through her roles with WHO on WHO COVID panels including the WHO R&D Expert Advisory Group for COVID-19 and the WHO Health Emergencies Program (WHE) Ad-Hoc Advisory Panel of Infection Prevention and Control Experts for Preparedness, Readiness and Response to COVID-19 (WHE-IPC-AP).